S20-082 Antiviral CRISPR Systems for Modulating Host Immune Response and Targeting the Virus Genome Researchers at Stanford have developed a CRISPR-based system to degrade viral RNA, with potential applications as both an anti-viral therapeutic and a prophylactic treatment against influenza, SARS-CoV-2, and other viruses. Lei Qi Marie La Russa Timothy Abbott David Lewis